Presbyopia Treatments by Mechanism of Action: A New Classification System Based on a Review of the Literature
Daniel H Chang,1 George O Waring 4th,2 Milton Hom,3 Melissa Barnett4 1Empire Eye and Laser Center, Bakersfield, CA, USA; 2Waring Vision Institute, Mt. Pleasant, SC, USA; 3Canyon City Eyecare, Azusa, CA, USA; 4University of California, Davis Eye Center, Sacramento, CA, USACorrespondence: Daniel H Cha...
Guardado en:
Autores principales: | Chang DH, Waring GO 4th, Hom M, Barnett M |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3b62238df19843e6897296cc48b36735 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Combinations of Pilocarpine and Oxymetazoline for the Pharmacological Treatment of Presbyopia
por: Francis W. Price, Jr., MD, et al.
Publicado: (2021) -
Six-month visual outcomes for the correction of presbyopia using a small-aperture corneal inlay: single-site experience
por: Moshirfar M, et al.
Publicado: (2016) -
Clinical Outcomes with a Novel Extended Depth of Focus Presbyopia-Correcting Intraocular Lens: Pilot Study
por: Iradier MT, et al.
Publicado: (2021) -
Patient and Economic Burden of Presbyopia: A Systematic Literature Review
por: Berdahl J, et al.
Publicado: (2020) -
FEATURES OF VISUAL PERCEPTION IN PATIENTS WITH PRESBYOPIA, DEPENDING ON THE TYPE OF INTRAOCULAR CORRECTION
por: A. G. Shchuko, et al.
Publicado: (2016)